SERVIFY
Servify , a leading provider of Extended Care and Product Protection solutions using its global, AI-enabled, digital platform, has announced hiring of senior leaders across regions and functions to drive its global expansion. Arun Verma, MS Kalsi, Kevin Cundiff, Edward Lee, Swetha Prashant, Peter Duesing, Sanghoon (Sam) Kwon, Hussein Hussein and Sergey Odinets have all been hired to bolster various verticals and regions within the organisation.
Arun Verma, with more than 20 years of experience, was appointed as the Chief Human Resources Officer . He has championed impressive success in people management across distinctly diverse industries such as Technology & Services, Finance, Management Consulting & FMCG. He worked as CHRO and Head of Administration of Beetel before Servify, and with the likes of Xerox India, McKinsey & Co., Reliance Capital Limited, and CavinKare in the past.
Makhan Singh Kalsi, also known as M S Kalsi, joins Servify as its Chief Service Officer after previously serving as the Chief Operations Officer for Digicare, a Quess Group Company. During his three years there, he scaled their operations multi-fold, with his enviable brand relationships and market reputation. He has also worked with LeEco, Samsung, Nokia, Canon, and Network Ltd in the past in various senior management positions.
Swetha Prashant joined Servify as Group General Counsel and shall be working closely with the leadership team to help scale and reinforce Servify’s legal capabilities. Swetha, a former partner of J. Sagar Associates (a leading law firm), has been practising law for more than 14 years with extensive experience in representing and advising both domestic and international clients in relation to cross border investments, M&A, JVs, private equity / venture capital, and general corporate commercial transactions and compliances across diverse sectors.
Kevin Cundiff joins Servify’s North American operations as Vice President, Partners & Account Management, and will manage all key partner relations. He has led teams responsible for product placement as well as client acquisition, development and retention in his previous roles and manage all key account relationships in North America. In the past, he has worked in senior positions at Penumbra Brands, uBreakiFix (acquired by Asurion), Fortegra (ProtectCELL parent company) and T-Mobile.
Edward Lee is an insurance industry veteran with a career spanning more than 20 years spearheaded market expansion, product development and regulatory compliance initiatives in support of global manufacturers, distributors and automotive dealer groups in both Canada and the United States for organisations such as Microsoft Corporation, CNH Industrial N.V., SquareTrade, HomeServe USA, Sears, General Motors Corp., Volvo North America, etc. He joins Servify as Vice President and Head of Insurance for North America and will also drive regulatory compliance in the warranty practice globally for Servify.
Sanghoon (Sam) Kwon joined Servify as a Senior Director and will manage Samsung as an OEM account for Servify. He comes with a rich experience which ranges from strategy building to managing global and regional businesses. He worked with Samsung Electronics in Korea and in other geographies in the past & Bolttech just before joining Servify. He is based in Seoul, South Korea.
The Technology function also sees addition of two key hires.
Dr. Peter Duesing, who became part of Servify after its acquisition of German based WebToGo, takes over the position of Vice President - Technology based out of Munich, Germany. He is now responsible for leading engineering teams for our Diagnostics and R&D functions and will also lead our patent portfolio expansion initiatives.
Ghanshyam Varindani joins Servify as Senior Director to lead the Data Engineering function. In previous roles, he has worked in senior roles at AirAsia in Malaysia and TCS leading Data Analytics Strategy and the Business Intelligence Roadmaps.
Additionally, to manage business operations in The Kingdom of Saudi Arabia & Russia, Hussein Hussein and Sergey Odinets have been respectively appointed as Regional Heads. They both have more than a decade of experience each working for top global brands.
“We are fortunate to build a global business that’s also growing massively. I am extremely proud to have these reputed leaders joining me to realise our vision. It’s always great people building great companies, and I am happy that getting great people hasn’t been a problem ever for us,” said Sreevathsa Prabhakar, Founder of Servify, on the expansion of global teams.
About Servify
Servify integrates multiple OEM Brands and their sales and service ecosystem through its product lifecycle management platform, to deliver great after-sales service experience. Started in 2015, India Headquartered Servify has spread its reach in multiple countries across the globe, partnering with over 75 OEM brands including top mobile device brands, retailers, distributors, insurers, service providers and carriers. The Servify platform processes more than 3 million transactions monthly, with 250k+ Platform users spread across retailers, service centres, contact centres and administration teams worldwide serving millions of consumers.
Additional information on Servify is available at www.servify.tech
View source version on businesswire.com: https://www.businesswire.com/news/home/20210804005106/en/
Link:
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Enginzyme and AGC Create Scalable Process for Key mRNA Ingredient12.1.2026 06:00:00 CET | Press release
At the mRNA Health conference in Berlin, enginzyme and AGC Inc. presented a scalable process to produce a key mRNA vaccine and therapy ingredient, N1-methylpseudouridine-5'-triphosphate (m¹ΨTP). The rapid growth of mRNA-based vaccines and therapeutics has driven significant demand for modified nucleotides like m¹ΨTP, which enhances mRNA stability and expression, while reducing immunogenicity. Enginzyme is a deep-tech company delivering optimized biomanufacturing solutions through cell-free enzyme engineering technology. AGC Inc. is a leading global player in fields spanning from architectural glass to chemicals and life science. AGC Inc. provides services in a wide range of life science fields, from synthetic pharmaceuticals and agrochemicals, to biopharmaceuticals and leading-edge cell and gene therapies, as well as messenger RNAs. The presentation in November detailed the latest collaboration between the companies, with a focus on the biomanufacturing of nucleotides for mRNA therapy,
Ant International Partners with Google’s Universal Commerce Protocol to Expand AI Capabilities12.1.2026 02:15:00 CET | Press release
Ant International, a leading global payment, digitisation, and financial technology provider, is collaborating on the launch of Google’s Universal Commerce Protocol (UCP), a new open standard for agentic commerce that works across the entire shopping journey — from discovery and buying to post-purchase support. UCP establishes a common language for agents and systems to operate together across consumer surfaces, businesses, and payment providers to enable commerce. So instead of requiring unique connections for every individual agent, UCP enables all agents to interact easily. UCP is built to work across verticals and is compatible with existing industry protocols like Agent2Agent (A2A), Agent Payments Protocol (AP2), and Model Context Protocol (MCP). “For agentic commerce to scale, it’s critical for the industry to align on a common set of standards. We are proud to have Ant International endorse the Universal Commerce Protocol as the foundation for that future,” said Ashish Gupta, VP
Torq Secures $140M Series D at $1.2B Valuation to Lead the AI SOC and Agentic AI Era11.1.2026 17:59:00 CET | Press release
Fueled by Massive Customer Adoption of AI Agents, Torq Scales the World’s First True AI SOC Platform and Accelerates Expansion into the U.S. Federal Market Torq, the established Agentic AI security operations pioneer, today announced it has closed a massive $140 million Series D funding round, propelling its valuation to $1.2 billion and total funding to $332M. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260112510774/en/ Led by Merlin Ventures—a leading cybersecurity fund renowned for its deep access to the U.S. commercial and Public Sector markets—with participation from all existing investors, including Evolution Equity Partners, Notable Capital, Bessemer Venture Partners, Insight Ventures Partners, and Greenfield Partners, this capital injection is a definitive investment in the future of security. Torq is driving the industry’s critical shift: the complete transformation of the Security Operations Center (SOC) through
Andersen udvider sine kompetencer med tilføjelsen af Scimitar9.1.2026 21:44:00 CET | Pressemeddelelse
Andersen Consulting har indgået en samarbejdsaftale med Scimitar, der er et firma med fokus på at accelerere innovation i biovidenskabsbranchen. Scimitar, der har hovedkvarter i USA, et førende konsulenthus inden for strategieksekvering for biovidenskabsbranchen. Virksomheden er specialiseret i design af driftsmodeller, digital transformation og organisatorisk forandring. Scimitar samarbejder med medicinal- og biotech-virksomheder om at accelerere innovation, styrke den driftsmæssige eksekvering og sikre compliance gennem hele produkters livscyklus. Deres praktiske og samarbejdsorienterede tilgang sikrer løsninger, der ikke blot er formålstjenlige, men også skalerbare. "Virksomheder inden for biovidenskabsbranchen befinder sig i en tid med hurtige videnskabelige fremskridt, stigende regulatorisk kompleksitet og et voksende behov for operationel agilitet, samtidig med at de holdes op mod de højeste standarder for patientsikkerhed og dataintegritet," udtaler Ramy Khalil, CEO i Scimitar.
Biocytogen and Acepodia Expand Collaboration Through Option-based Evaluation Framework for First-in-Class Bispecific and Dual-Payload ADCs (BsAD2C)9.1.2026 13:00:00 CET | Press release
Expanded collaboration builds on Acepodia and Biocytogen’s recent co-development efforts to evaluate selected bispecific antibody and dual-payload ADC programs Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315) and Acepodia (6976:TT), today announced that the companies have entered into an option and license agreement designed to enable the structured evaluation of bispecific antibody-drug conjugate (BsADC) programs to further advance the development of dual-payload bispecific antibody-drug conjugates (BsAD2Cs). The agreement grants Acepodia an option to obtain an exclusive worldwide license from Biocytogen for two BsADC programs. Under the terms of the agreement, Biocytogen is eligible to receive an upfront option fee and, upon Acepodia’s exercise of the option, additional payments including option exercise fees, development, regulatory, and commercial milestone payments, as well as royalties on future product sales. The financial terms of the agreem
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
